Annual Program Provides Advanced Education and Hands-On Experience to
Future Eye Care Professionals
SAN RAMON, Calif., March 3, 2022—For the fifth consecutive year, CooperVision and its Specialty EyeCare unit held their Contact Lens and Pediatric Residency Summit. The event brought together contact lens and pediatric residents from across the U.S. and Canada to learn about the latest developments in the company’s broad portfolio of soft and specialty contact lenses, as well as CooperVision’s continued efforts to establish myopia management as the standard of care.
The theme of the three-day program was Act Now, Change Tomorrow, which provided residents with updates surrounding CooperVision’s extensive portfolio of soft and specialty contact lenses, including Onefit MED scleral contact lenses, MiSight® 1 day for myopia control*, and Paragon® CRT and iSee® ortho-k lenses for myopia management. In addition to learning strategies to advance overall patient care, residents participated in hands-on and instrument-driven specialty contact lens fittings.
“CooperVision remains committed to supporting the advancement of the profession through providing collaborative, hands-on educational events,” said Michele Andrews, OD, Vice President, Professional & Governmental Affairs, Americas, CooperVision. “We look forward to continued partnerships with these residents as they take their residency skillset and experiences into their careers.”
During the meeting, clinical and research experts across the contact lens, myopia management and irregular cornea categories hosted a series of workshops and breakout sessions on a variety of topics including how to maximize CooperVision’s entire contact lens portfolio, lens options for patients of all ages and conditions, common misconceptions about myopia management, modifications for solving complex scleral lens cases, and how to build a contact lens practice. Discussion leaders included Dr. Leah Johnson of CooperVision Specialty EyeCare, Dr. Maria Liu, Dr. Aaron Neufeld, Dr. Sarah Singh and Dr. Ashley Tucker, as well as several members of CooperVision’s Professional Affairs team.
# # #
*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Maggie Munley, Counselor, McDougall Communications
firstname.lastname@example.org or +1-585-434-2149